XPrize Competition Hopes to Encourage 'Frequent, Fast, Cheap, and Easy' COVID-19 Testing
The international competition's goal is to spark innovation and accelerate safe returns to work, school, and other public activities.
High-Throughput Diagnostic COVID-19 Sequencing Assays May Enable Large-Scale Testing
Assays like SwabSeq, Dx-Seq, and LAMP-Seq promise to analyze tens to hundreds of thousands of samples in parallel but might be constrained by sample availability.
In Brief This Week: CareDx, Natera, OncoCyte, and More
News items for the in vitro diagnostics industry for the week of Jan. 27, 2020.
In Brief This Week: Agilent, Becton Dickinson, T2 Biosystems, And More
Agilent Technologies announced this week that it has agreed to acquire privately-held ProZyme, a provider of glycan analysis reagents, kits, and standards.
The number of institutions offering clinical exome or genome tests to healthy individuals keeps increasing, but the practice remains controversial among medical experts.